ETHAN SNYDER: Open Payments
NPI 1508595729 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 80 payments from 16 companies in 2025. Trend: 2023 $14 · 2024 $1,215 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $491 |
| ABBVIE INC. | 14 | $277 |
| LEO Pharma Inc. | 12 | $237 |
| Janssen Biotech, Inc. | 10 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Galderma Laboratories, L.P. | 5 | $96 |
| Organon LLC | 5 | $86 |
| Amgen Inc. | 3 | $62 |
| Verrica Pharmaceuticals Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
Products named: DUPIXENT, SKYRIZI, ADBRY, TREMFYA, NEMLUVIO, COSENTYX, VTAMA, Otezla.
Industry payments across CA — which companies pay providers there.
